[1]
N. Tuvshinbayar, R. Amaraa, B. Burmaajav, B. Gegeebadrakh, and O. Baatarkhuu, “CLINICAL AND VIRUSOLOGICAL OUTCOMES OF TENOFOVIR ALAFENAMIDE TREATMENT IN PATIENTS WITH HEPATITIS B VIRUS INFECTION”, ESU, pp. 14-24, Sep. 2022.